24242-99-7

Basic information

• Product Name: 1-[4-(3-METHYL-BUTOXY)-PHENYL]-ETHANONE
• Synonyms: Acetophenone,4'-(isopentyloxy)- (8CI); 4'-(Isopentyloxy)acetophenone;p-(Isopentyloxy)acetophenone
• CAS NO: 24242-99-7
• Molecular Formula: C₁₃H₁₈O₂
• Molecular Weight: 206.2808
• Mol File: 24242-99-7.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 313.8°Cat760mmHg
• Flash Point: 130.2°C
• Appearance: /
• Density: 0.975g/cm³
• Vapor Pressure: 0.000485mmHg at 25°C
• Refractive Index: 1.493
• CAS DataBase Reference: 1-[4-(3-METHYL-BUTOXY)-PHENYL]-ETHANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[4-(3-METHYL-BUTOXY)-PHENYL]-ETHANONE(24242-99-7)
• EPA Substance Registry System: 1-[4-(3-METHYL-BUTOXY)-PHENYL]-ETHANONE(24242-99-7)

Safety Data

• Hazardous Substances Data: 24242-99-7(Hazardous Substances Data)

Usage

Type of compound

Ketone

Structure

A phenyl group substituted by a 3-methyl-butoxy group

Common uses

a. Intermediate in the synthesis of pharmaceuticals and organic compounds
b. Production of perfumes and fragrances due to aromatic properties

Industrial applications

Potential use as a solvent or reagent in chemical processes

Safety concerns

May pose health risks if not properly managed and stored

InChI:InChI=1/C13H18O2/c1-10(2)8-9-15-13-6-4-12(5-7-13)11(3)14/h4-7,10H,8-9H2,1-3H3

Upstream product

• 107-82-4 i-pentyl bromide 
• 99-93-4 4-Hydroxyacetophenone 
• 1129-64-2 isopentyl phenyl ether 
• 108-24-7 acetic anhydride 
• 75-36-5 acetyl chloride 

Downstream Products

• 1041166-58-8 2-bromo-1-[4-(isopentyloxy)phenyl]ethanone 
• 92595-23-8 [1-[4-(3-Methyl-butoxy)-phenyl]-eth-(E)-ylidene]-phenyl-amine 
• 47237-16-1 1-(4-isopentyloxy-phenyl)-3-piperidino-propan-1-one 

Relevant articles and documents

Lipopeptide Compounds and Their Use

The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain lipopeptide compounds comprising a cyclic peptide bearing a lipid side chain (for convenience, collectively referred to herein as “LP compounds”), which, inter alia, are antimicrobial, particularly antibacterial. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to provide an antimicrobial function, particularly an antibacterial function, and in the treatment of diseases and conditions that are mediated by microbes, particularly bacteria, that are ameliorated by the antimicrobial function, particularly an antibacterial function, including bacterial diseases, optionally in combination with another agent, for example, another antibacterial agent.